Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga A Krasilnikova

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biotechnology Journal|October 4, 2021
Quantitative human physiology: An introduction guide for advanced tissue engineeringIlya D Klabukov, Olga A Krasilnikova, Denis S Baranovskii
Cytotherapy|May 14, 2021
The new legal framework for minimally manipulated cells expands the possibilities for cell therapy in RussiaOlga A Krasilnikova, Ilya D Klabukov, Denis S Baranovskii, et al.
Current Medical Research and Opinion|November 19, 2020
Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumoniaDenis S Baranovskii, Ilya D Klabukov, Olga A Krasilnikova, et al.
Bioimpacts : BI|January 28, 2022
Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up periodNadezhda V Maksimova, Anna V Michenko, Olga A Krasilnikova, et al.
Bioengineering (Basel, Switzerland)|November 24, 2022
Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In SituOlga A Krasilnikova, Denis S Baranovskii, Anna O Yakimova, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biotechnology Journal|October 4, 2021
Quantitative human physiology: An introduction guide for advanced tissue engineeringIlya D Klabukov, Olga A Krasilnikova, Denis S Baranovskii
Cytotherapy|May 14, 2021
The new legal framework for minimally manipulated cells expands the possibilities for cell therapy in RussiaOlga A Krasilnikova, Ilya D Klabukov, Denis S Baranovskii, et al.
Current Medical Research and Opinion|November 19, 2020
Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumoniaDenis S Baranovskii, Ilya D Klabukov, Olga A Krasilnikova, et al.
Bioimpacts : BI|January 28, 2022
Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up periodNadezhda V Maksimova, Anna V Michenko, Olga A Krasilnikova, et al.
Bioengineering (Basel, Switzerland)|November 24, 2022
Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In SituOlga A Krasilnikova, Denis S Baranovskii, Anna O Yakimova, et al.
Pageof 1